Germany warned over price curbs on drugs
Add BT as a preferred sourceDeeperDive is a beta AI feature. Refer to full articles for the facts.
Berlin
BAYER AG, Roche Holding AG and other drugmakers are warning that a German government proposal to tighten price controls on prescription drugs could end up restricting access to new medicines in Europe's biggest healthcare market.
The proposal "lacks a fair balance between measures to foster innovation and cost-containment", said Dieter Weinand, pharmaceuticals chief at Bayer. "Incremental innovation is not recognised and rewarded adequately."
Share with us your feedback on BT's products and services
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Eurokars Group introduces rental car franchises Enterprise Rent-A-Car, National Car Rental, and Alamo to Singapore
20 photos that show how dramatically Singapore has changed in two decades
Singapore’s key exports up 15.3% in March from electronics surge, exceeding forecasts
